Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000213508 | SCV000271283 | likely pathogenic | Primary dilated cardiomyopathy | 2020-12-09 | criteria provided, single submitter | clinical testing | The p.Glu25936X variant in TTN has not been previously reported in individuals with TTN-related disorders, such as dilated cardiomyopathy and neuromuscular conditions and was absent from large population studies. This nonsense variant leads to a premature termination codon at position 25936, which is predicted to lead to a truncated or absent protein. Nonsense and other truncating variants in TTN are strongly associated with DCM, particularly if they are located in the exons encoding for the A-band (Herman 2012, Pugh 2014) and/or are located in an exon that is highly expressed in the heart (Roberts 2015). The p.Glu25936X variant is located in the A-band in the highly expressed exon 275. In summary, although additional studies are required to fully establish its clinical significance, the p.Glu25936X variant is likely pathogenic for autosomal dominant dilated cardiomyopathy. ACMG/AMP criteria applied: PVS1, PM2. |
CHEO Genetics Diagnostic Laboratory, |
RCV000769913 | SCV000901339 | likely pathogenic | Cardiomyopathy | 2019-11-19 | criteria provided, single submitter | clinical testing |